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Abstract
In rats, a shift from somatotroph dominance to lactotroph
dominance during pregnancy and lactation is well reported.
Somatotroph to lactotroph transdifferentiation and increased
lactotroph mitotic activity are believed to account for this and
associated pituitary hypertrophy. A combination of cell death
and transdifferentiation away from the lactotroph phenotype
has been reported to restore non-pregnant pituitary pro-
portions after weaning. To attempt to conﬁrm that a similar
process occurs in mice, we generated and used a transgenic
reporter mouse model (prolactin (PRL)-Cre/ROSA26-
expression of yellow ﬂuorescent protein (EYFP)) in which
PRL promoter activity at any time resulted in permanent,
stable, and highly speciﬁc EYFP. Triple immunochemistry for
GH, PRL, and EYFP was used to quantify EYFPCve,
PRLKve, and GHCve cell populations during pregnancy
and lactation, and for up to 3 weeks after weaning, and
concurrent changes in cell size were estimated. At all stages,
the EYFP reporter was expressed in 80% of the lactotrophs,
but in fewer than 1% of other pituitary cell types, indicating
that transdifferentiation from those lactotrophs where
reporter expression was activated is extremely rare. Contrary
to expectations, no increase in the lactotroph/somatotroph
ratio was seen during pregnancy and lactation, whether
assessed by immunochemistry for the reporter or PRL:
ﬁndings conﬁrmed by PRL immunochemistry in non-
transgenic mice. Mammosomatotrophs were rarely
encountered at the age group studied. Individual EYFPCve
cell volumes increased signiﬁcantly by mid-lactation
compared with virgin animals. This, in combination with a
modest and non-cell type-speciﬁc estrogen-induced increase
in mitotic activity, could account for pregnancy-induced
changes in overall pituitary size.
Journal of Endocrinology (2010) 205, 49–60
Introduction
Estrogen is believed to be responsible both for increased
anterior pituitary mitotic variability in estrous-cycling
females compared with male rats (Oishi et al. 1993, McNicol
& Carbajo-Perez 1999, Nolan & Levy 2009a) and for the
physical expansion of the pituitary during pregnancy and
lactation (Gonzalez et al. 1988, Elster et al. 1991, Dinc et al.
1998, Chanson et al. 2001). Several morphometric studies
have identiﬁed the prolactin (PRL) cell population as the
main estrogen target (Asa et al. 1982, Haggi et al. 1986,
Stefaneanu et al. 1992), and various mechanisms including
‘striking proliferation’ (Orgnero de Gaisan et al. 1993, Aoki
et al. 1996), apoptosis (Aoki et al. 1996, Ahlbom et al. 1998),
‘massive degeneration’ (Orgnero de Gaisan et al. 1993),
autolytic changes (Aoki et al. 1996), and bi-directional
lactotroph to somatotroph transdifferentiation (Porter et al.
1991) have been implicated to account for it. Although recent
studies indicate that the mitotic effects of high-dose estrogen
in male rats are transient (Nolan & Levy 2009a) and not
conﬁned to PRL cells (Nolan & Levy 2009b), these data
suggest that there is a real shift in relative proportions of
different anterior pituitary cell subtypes during reproduction.
The objective of the present study was to identify changes in
lactotroph/somatotroph ratio during pregnancy, lactation,
and weaning, and to quantify the contribution of lactotroph
to somatotroph transdifferentiation to these processes.
To identify a potential transdifferentiating cell population, a
3.2 kb fragment of the rat PRL promoter that was able to
faithfully reproduce endogenous PRL promoter activity
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recombinase in the lactotrophs of PRL-Cre transgenic mice.
In combination with the ROSA26-expression of yellow
ﬂuorescent protein (EYFP) reporter mouse, which has a
ﬂuorescent marker for Cre-driven recombination inserted in
the ubiquitously expressed ROSA26 gene, PRL-Cre/
ROSA26-YFP mice express EYFP from the ROSA26
promoter in any cell that has expressed the PRL transgene
promoter at any time (Srinivas et al. 2001). The EYFP
reporter is cytosolic, and its expression is not dependent on
PRL promoter activity once recombination has occurred.
As well as permanently marking Cre-positive cells, the use of
a ubiquitously expressed cytoplasmic reporter, rather than of
stored PRL to identify lactotrophs, overcomes the potential
of failing to identify lactotrophs which have secreted a large
proportion of their hormone.
To exploit the principal power of the Cre recombinase
model, which is speciﬁcity rather than sensitivity, the present
study was designed particularly to explore changes seen in
females during the weeks after weaning, and to compare the
results with ﬁndings after withdrawal of high pharma-
cological levels of estrogen in males. If PRL- and EYFP-
expressing cells are deleted by cell death at weaning, the size
of the EYFPCve cell subpopulation should abruptly drop
relative to that of EYFPKve cells. If intracellular PRL
peptide levels fall to below immunocytochemical detection
limits at this time, a population of EYFPCve but PRL
peptide-immunonegative cells should emerge. An increased
proportion of EYFPCve, PRLKve, and GHCve cells
would strongly support transdifferentiation as a mechanism
for numerical regression of lactotrophs following weaning.
By quantifying changes in the relative proportions of
different subpopulations in freshly dispersed cells, care was
taken to ensure that the results were not confounded by
changes in cell size (Floderus 1944) or by difﬁculties
accurately quantifying numbers of closely associated,
relatively polymorphic cells of similar phenotype in tissue
sections. Cell size measurements were assessed directly from
still images of freshly dispersed cells and by ﬂow cytometry
forward scatter in virgin and end of ﬁrst week lactating
PRL-Cre/ROSA26-YFP mice.
Materials and Methods
Animals and treatments
A transgene construct with 3.2k bo f5 0 rat PRLpromoter and
1.7k b o f 3 0 PRL sequence driving Cre recombinase
expression was used to generate the PRL-Cre transgenic
mice. These were crossed with ROSA26-YFP reporter
mice (Srinivas et al. 2001). Double heterozygous PRL-Cre/
ROSA26-EYFP mice (of a mixed C57BL/6, C57BL/10, and
CBA/Ca genetic background) were bred from a single
homozygous transgenic male crossed with C57BL/6 females.
At 6 weeks of age, virgin females were mated, and groups of
dams were killed at weekly intervals throughout the lactation
and weaning period. Age-matched non-transgenic C57BL/6
females and virgin transgenic females served as controls (nZ8
in all groups).
In experiments to assess the effects of withdrawal of
exogenous estrogen in double heterozygous PRL-Cre/
ROSA26-YFP male mice, animals were given high-dose
s.c. injections of estrogen (100 mg1 7 b-estradiol
(E2; w1.3 mg/kg per day), E-8875 Sigma dissolved in
dimethylsulfoxide (DMSO) and sesame oil) or vehicle
(100 ml total volume) every 3 days for 15 days as described
(Nolan & Levy 2006b, 2009a). Estrogen was measured in
trunk blood samples, and changes in pituitary cellular
subpopulations were assessed over the subsequent 15 days as
described below.
Pituitary cell dispersal
Single pituitary glands were cut into small pieces, and were
dispersed using collagenase A (2.3 mg/ml, batch 70214221
Roche), trypsin (1 mg/ml, batch 10208700 Roche), and
DNase 1 (0.0458 mg/ml, batch 11898300 Roche) in
Hank’s balanced salt solution (HBSS, Invitrogen) for 1 h at
37 8C with continuous stirring and gentle trituration at least
20 times using a ﬂame-rounded glass pipette every 15 min.
Dispersal typically yielded a little over 600 000 viable (trypan
blue excluding) single cells per pituitary after 60–75 min.
Very few if any cellular aggregates remained after this process.
Cell suspensions were therefore not ﬁltered prior to the
ongoing studies.
The effects of pregnancy, lactation, and weaning on PRL/GH cell
ratio and lactotroph to somatotroph transdifferentiation
Isolated pituitary cells from groups of eight virgin
PRL-Cre/ROSA26-EYFP mice and similar groups at term,
at the end of the ﬁrst, second, and third weeks of lactation,
and at the end of the ﬁrst, second, and third weeks after
weaning were resuspended in DMEM containing 10% FCS,
and were then left to settle onto poly-L-lysine-coated slides
for 2 h in a humidiﬁed container at 37 8C. Attached cells were
ﬁxed in 4% paraformaldehyde in PBS at room temperature
for 10 min, washed, and stored in PBS at 4 8C until triple
immunocytochemistry for EYFP, PRL, and GH. Slides were
blocked in 10% normal goat serum (Vector Laboratories Inc.
Burlingame, CA, USA) and 0.1% Triton X-100 in PBS for
1 h at room temperature, and were then incubated overnight
in chicken anti-GFP which cross-reacts with EYFP (1:1000,
Abcam, Cambridge, UK), rabbit anti-PRL, and monkeyanti-
GH sera (1:5000, AFP425-10-91 and 1:10 000, AFP411S
kindly provided by A F Parlow, NIDDK) at 4 8C. After three
PBS washes, the slides were incubated at room temperature
with Alexa Fluor-488 goat anti-chicken IgG (1:500,
Molecular Probes, Paisley, UK; Invitrogen), Alexa Fluor-
555 goat anti-human IgG (1:200, Molecular Probes),
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Probes) for 4 h in the dark. Slides were washed in PBS and
mounted using ‘Fluorsave’ (Calbiochem, Nottingham, UK).
A minimum of 2000 cells were assessed per animal by
overlaying ﬁelds captured under visible and u.v. light (Zeiss
ﬁlter sets 02, 09, and 15) at 200! magniﬁcation.
The entire immunocytochemical staining reaction was
repeated using rabbit anti-PRL and chicken anti-GFP
(for EYFP) only followed by Cy3 goat anti-rabbit IgG
(1:200, Abcam), Alexa Fluor-488 goat anti-chicken IgG
(1:500), and 40,6-diamidino-2-phenylindole (DAPI) (1:100,
Sigma) in PRL-Cre/ROSA26-EYFP and in groups of
wild-type (C57BL/6) females before mating, at term, after
14 days of lactation and 7 days after weaning.
The effects of pregnancy and lactation on mean pituitary cell
diameter and EYFPCve lactotroph diameter
Pituitary glands from three females at the end of the ﬁrst week
of lactation and three age-matched virgin females were
dispersed as described above, and were allowed to settle onto
poly-L-lysine-coated slides in a humidiﬁed box at 37 8C. After
2 h, cells were adherent to the slides but nevertheless
remained spherical, allowing the diameters of living
EYFPCve cells, EYFPKve cells, and all cells (EYFPCve
and EYFPKve combined) to be measured from u.v.
and visible light photographs of four ﬁelds per animal at
200! magniﬁcation using the public domain Java-based
image processing program ‘ImageJ’.
Figure1 Examplesofmonodispersed pituitarycellsfromPRL-Cre/ROSA26-EYFP micedoubleimmunostained forprolactin(panelA)and
EYFP (panel B) with superimposed images of the same ﬁeld in panel C. It can be seen that with few exceptions (arrows with open heads),
the EYFPCve cells are also positive for prolactin, but several prolactinCve cells are negative for EYFP (examples of which are shown by
the arrows with solid heads). Panels D and E show the sample ﬁeld of cells triple immunostained for prolactin (panel D), GH (panel E),
and EYFP (not shown), with panels D and E merged in panel F. The entirely distinct cell populations shown illustrate the rarity of
mammosomatotrophs. Panels G, H, and I show the same ﬁeld triple immunostained for EYFP, GH, and prolactin, with panel J showing
merged ﬁelds with occasional prolactin to GH transdifferentiated (i.e. EYFPCve and GHCve but prolactinKve) cells (arrowed).
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cell cross-sectional areas
Pituitaries from three lactating females 1 week after delivery
and three age-matched virgin females were dispersed as
described above and resuspended in HBSS with 0.5% BSA
and 2 mM EDTA, and mean EYFPCve and EYFPKve cell
sizes were estimated by ﬂow cytometry using a FACS LSRII
running ‘FACS Diva 5’ software (BD Biosciences, San Jose,
CA, USA) and were analyzed with Flowjo software (Treestar,
Inc., Ashland, OR, USA). A guide to the relationship
between forward scatter and cell cross-sectional area was
provided by comparison with a series of commercial
non-ﬂuorescent polystyrene microspheres from 2- to
15.3-mm diameter (Spherotech sizing beads, Spherotech Inc.,
Lake Forest, IL, USA).
The effects of estrogen withdrawal on PRL/GH cell ratio and
lactotroph to somatotroph transdifferentiation in male mouse
pituitary glands
Groups of 6-week-old PRL-Cre/ROSA26-EYFP males
were given s.c. injections of estrogen (100 mgE 2 dissolved
in DMSO and sesame oil) or vehicle every 3 days for 15 days.
Groups of animals were then killed at 3-day intervals for
the next 15 days from 1 day after cessation of estrogen
injections (nZ8), and pituitary glands were collected for
analysis as described above. Trunk blood was assayed
for estrogen (nZ2–3).
All results are expressed as the meanGS.E.M.w i t h
differences between groups evaluated using one-way
ANOVA followed by Tukey–Kramer multiple comparison
post-tests. P!0.05 was considered statistically signiﬁcant.
Results
Restriction of expression of EYFP to lactotrophs in
PRL-Cre/ROSA26-EYFP female mice
PRL and GH double immunohistochemistry in cells
dispersed from 12-week-old PRL-Cre/ROSA26-YFP
female mice shows that EYFP expression is almost entirely
limited to PRL cells, but that not all immunohistochemically
identiﬁed PRL cells are EYFPCve (Fig. 1, panels A and B).
In the essentially dopamine-free environment of primary cell
culture for 5 days (120 000 cells in 2 ml DMEM containing
10% FCS), therewas no evidence that increasedactivityof the
PRL promoter resulted in additional recombination events
Figure 2 Change in pituitary wet weights of virgin 12-week-old
PRL-Cre/ROSA26-EYFP mice at term, at the end of the ﬁrst, second,
and third weeks of lactation, and one week, two weeks, and
three weeks after weaning. For each group, nZ8. Means and S.E.M.
are shown. *P!0.05, **P!0.01, and ***P!0.001 compared with
virgin controls (panel A). Pituitary weights increased from virgin to
term by 25%, from 1.82G0.057 to 2.28G0.12 mg. Changes in the
proportion of lactotrophs assessed in single cell dispersals of
pituitary glands from virgin C57BL/6 and PRL-Cre/ROSA26-EYFP
mice at the same time points are shown in panel B (nZ16 for each
time point) using double (PRL and EGFP) and triple (PRL, GH, and
EGFP) immunochemistry reactions. Panel C shows concurrent
changes in the proportion of GH-positive cells and transdiffer-
entiating cells (i.e. EYFP and GHCve, and prolactin negative).
Means and S.E.M. are shown. *P!0.05, **P!0.01, and
***P!0.001 compared with virgin animals. With the exception
of the signiﬁcant drop in number of prolactin-immunopositive cells
between term and the end of the ﬁrst week of lactation (P!0.05)
(panel B), all the signiﬁcance markers refer to comparisons with
virgin animals.
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1 mM metoclopramide (in PBS, Sigma: data not shown). The
percentage of PRLCve cells in 12-week-old PRL-Cre/
ROSA26-YFP virgin females averaged 40.8G1.3%, of which
79% (i.e. 32.2G1.1% of total cells) were EYFPCve. GHCve
cells comprised w34.4G1.8% of the total cells present. PRL-
and GH-positive (i.e. conventionally identiﬁed mammoso-
matotroph) cells were rare, averaging 0.2G0.06% of the cells
in pregnant females and 0.3G0.2% of the total cells in
estrogen-treated males (panels D and Ein Fig. 1showa typical
triple immunostained ﬁeld without a single mammosomato-
troph). EYFPCve ‘lactotrophs’ that had transdifferentiated
from the lactotroph phenotype to the somatotroph phenotype
(GHCve, EYFPCve, and PRLKve) represented !1% of
pituitary parenchymal cells counted (Fig. 1, panels G, H, I,
and J). Cells that had transdifferentiated away from the PRL
phenotype (i.e. PRLKve and EYFPCve) and that were
also GHKve were seen but were extremely rare, comprising
!0.05% of the cells present.
The effects of pregnancy, lactation, and weaning on pituitary
weight and the proportion of PRL, EYFP, and GH cells
As expected, pituitary weight in PRL-Cre/ROSA26-EYFP
mice increased signiﬁcantly during pregnancy (Fig. 2, panel
A),andreachedapeakduringmid-lactation(38%heavierthan
virgins)beforereturning to a size 10–14% greater than, butno
longer signiﬁcantly different from that of the virgin animals.
Strikingly, and contrary to expectations, there was no
discernable increase in the relative proportion of classical
lactotrophs (i.e. PRLCve cells) during pregnancy (dashed
line) or lactation in C57BL/6 or PRL-Cre/ROSA26-EYFP
mice, or in the proportion of EYFPCve cells (accounting for
a subpopulation of four of ﬁve classical lactotrophs) during
pregnancy or lactation in PRL-Cre/ROSA26-EYFP mice
(Fig. 2, panel B). Neither was a reciprocal decrease in the
relative proportion of somatotroph cells evident during this
period (Fig. 2, panel C). Nevertheless, there was a slight
increase in the proportion of GHCve cells and a reciprocal
downward trend in PRLCve and EYFPCve cells at weaning
(Fig. 2, panels B and C).
Transdifferentiating cells, that is, EYFPCve, GHCve yet
PRLKve cells, gradually accumulated through pregnancy,
lactation, and weaning from 0.2G0.05% to a maximum of
0.9G0.17% 3 weeks after weaning (Fig. 2, panel C). In
keeping with the absence of a decrease in GHCve cells or
increase in classical lactotrophs or EYFPCve cells during
pregnancy and lactation, and despite the slight reciprocal
changes in GHCve cells and PRLCve and EYFPCve cells at
weaning, there was no evidence of an abrupt increase in the
prevalence of transdifferentiating cells at any time. Neitherdid
a group of EYFPCve but PRLK and GHKve cells emerge,
with the prevalence of this phenotype remaining extremely
low throughout (!0.05% of the total cells).
A downward rather than upward trend in the proportion of
lactotrophs (either PRLCve or EYFPCve) was evident at
term compared with the virgin animals (Fig. 2, panel B), with
a further slight decline during lactation. There were no
signiﬁcant changes in PRLCve or EYFPCve cell numbers
from term (rather than virgin) through any stages of lactation
or weaning with the exception of PRL-immunopositive cells
1 week after weaning in PRL-Cre/ROSA26-EYFP mice,
which were slightly reduced in number (P!0.05). There
were no consistent changes in the proportion of EYFPCve
PRL cells at any time. The proportions of PRLCve cells
were consistently higher in C57BL/6 mice than in PRL-
Cre/ROSA26-EYFP mice.
The effects of pregnancy and lactation on directly measured mean
pituitary cell diameter and EYFPCve lactotroph diameter
A comparison of all cells and all EYFPKve freshly isolated
anterior pituitary cells from virgin PRL-Cre/ROSA26-
EYFP mice with isolated cells from animals entering the
second week of lactation revealed no signiﬁcant differences in
directly measured cell diameter (44.6G0.6v s4 4 .8G0.5 and
44.2G0.8v s4 3 .6G0.8 respectively (meanGS.E.M. arbitrary
units)). In contrast, EYFPCve cells increased modestly but
signiﬁcantly in diameter from 46.0G0.48 pixels in virgin
animals to 49.0G0.95 pixels during lactation (P!0.05),
equivalent to a 20% increase in volume.
The effects of pregnancy on EYFPCve and EYFPKve pituitary
cell cross-sectional areas estimated using FACS
No changes in mean EYFPKve cell volumes were seen
during pregnancy and lactation (Table 1). In contrast,
EYFPCve cells increased in calculated volume by just over
Table 1 Forward scatter on FACS analysis of expression of yellow ﬂuorescent protein (EYFP)Cve and EYFPKve cells from virgin and end of
ﬁrst week of lactation PRL-Cre/ROSA26-EYFP mice, and changes in cell cross-sectional areas derived from comparison with 2-, 3.3-, 5.03-,
7.66-, 10-, and 15.3-mm diameter standards. Cell diameters and volumes were calculated from cross-sectional areas (see Fig. 3)
ScatterGS.E.M.
(arbitrary)
Area (mm
2)
measured
Diameter (mm)
calculated
Volume (mm
3, i.e. fL)
calculated
EYFPCve virgin 118 000G7767 209 16.3 2273
EYFPCve lactating 167 250G1548 312 19.9 4146
EYFPKve virgin 130 333G1202 235 17.3 2710
EYFPKve lactating 131 000G408 236 17.3 2727
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about 50% when compared with EYFPKve cells (Fig. 3,
panels A, B and C).
The effects of estrogen withdrawal on PRL/GH cell ratio and
lactotroph to somatotroph transdifferentiation in male mouse
pituitary glands
In response to repeated, high-dose s.c. injection (equivalent at
the start of the experiment to 1300 mg/kg per day),
circulating estrogen levels peaked at 1.5 ng/ml (similar to
levels reported in 20-day gestation mice (Zhang et al. 1999)),
and returned over 10 days to levels indistinguishable
from sham after treatment withdrawal (Fig. 4, panel A).
Body weight increased by about 10% during high-dose
estrogen treatment, matching normal somatic growth in
control animals, then declined during the week following
cessation of estrogen injections before catching up by day
25, 10 days after the last dose of estrogen (Fig. 4, panel B).
Pituitary size increased signiﬁcantly in response to estrogen
treatment, reaching 149% of mean control values
(2.54G0.075: P!0.01) 4 days after the last dose of estrogen
(Fig. 4, panel C). Pituitary size subsequently decreased,
returning to 15% greater than untreated controls by 10 days
after the last dose of estrogen (PZNS) and remaining at that
size to the end of the experiment on day 31, 16 days after the
last estrogen injection (Fig. 4, panel C).
In contrast to the response to physiological estrogen in
female mice, pharmacological levels of estrogen in males
produced an increase in the proportion of PRLCve cells
(by 35–45%) and EYFPCve cells (by 1.7- to 2-fold) and a
reciprocal reduction in the proportion of GHCve cells (by 17
to 19%; Fig. 5, panels A, B, and C respectively). There was no
evidence of an increase in PRL to GH transdifferentiating
cells after estrogen withdrawal (Fig. 5, panel D). Comparing
average total cell counts during the ﬁrst and second weeks
after estrogen withdrawal (nZ24: Fig. 5, panel E) or all
estrogen-treated animals (nZ47: Fig. 5, panel F) with
Figure 3 Changes in average size of EYFPCve and EYFPKve
pituitary cells (solid lines and dashed lines in panel A respectively)
derived from virgin and lactating PRL-Cre/ROSA26-EYFP mice
using FACS (panels A and B). The increase in the size of the EYFP
Cve population is shown by the open arrow (panel B). Panel C
shows changes in mean forward scatter in comparison to a set of six
polystyrene bead standards (open square symbols) plotted as
cross-sectional areas. The extrapolated (dashed) line was used to
derive approximations of changes in cross-sectional areas of
EYFPCve and EYFPKve cells from virgin and end of ﬁrst week of
lactation PRL-Cre/ROSA26-EYFP mice (open circles). Differences
in refractive index and resistance to deformation between pituitary
cells and beads, and the effects of variable cytoplasm to nuclear
ratio as well as characteristics of the laser signiﬁcantly limit
derivation of quantitative information. Despite these caveats,
qualitatively, the mean cell volume of the EYFPCve lactotroph
population unequivocally increased from virgin to end ofﬁrst week
of lactation compared with the EYFPKve population, which
remained relatively unchanged in size.
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conﬁrmed the same trend toward an estrogen-induced
increase in PRL/GH cell ratio.
Discussion
It has been generally accepted that there is a switch in
secretory subpopulations in the anterior pituitary from
somatotroph dominance in the non-gravid state to lactotroph
dominance during pregnancy and lactation, then back again
after weaning. The place of transdifferentiation as a
contributory mechanism to explain this post-developmental
remodeling has to some extent been driven by the lack of
evidence of trophic effects of sufﬁcient amplitude to account
for the presumed changes (Nolan & Levy 2009a,b) and
extrapolated from lineage studies using ablation techniques,
and from immunohistochemical colocalization and reverse
hemolytic plaque assays carried out in fetal and neonatal life
(Frawley & Boockfor 1991). In human fetal pituitary glands
examined between 18 and 22 weeks of gestation (nZ5), the
majority of PRL-secreting cells have been reported to
produce and secrete GH (Mulchahey & Jaffe 1988). In rats,
pure PRL cells have been reported to make up 10% of the
pituitary by postnatal day 5 with mammosomatotrophs
contributing a further 36% (Hoefﬂer et al. 1985). In mice,
early targeted ablation of PRL and GH cells to address the
hypothesis that GH/PRL bihormonal cells might form a
common progenitor population identiﬁed a replicating
GH-expressing cell, a ‘stem somatotroph’, as an essential
common precursor to the population of post-mitotic PRL
cells (Borrelli et al. 1989). Using the identical rGH promoter
sequence to that used above, however, the persistence of a
population of pure PRL cells after GH and GH/PRL cell
ablation implicated that at least a proportion of PRL cells
develop entirely independently of all somatotroph lineages
(Behringer et al. 1988). The latter ﬁnding was supported more
recently by a GH promoter-driven Cre recombinase
transgenic mouse model in which 90% of PRL cells appeared
to develop entirely independently of the GH lineage (Luque
et al. 2007) (as it does in some non-mammalian species
(Fu et al. 2004)), and by the observation, also in mice, that
estrogen can induce PRL cells to appear prior to the onset of
GH gene expression on day 15 of fetal life (Matsubara et al.
2001, Ogasawara et al. 2009).
Integrating what appear to be mutually exclusive ﬁndings
into a single model is complicated as technical constraints,
unpredictable bystander effects, and different congenic
Figure 4 Panel A shows the rapid decline in circulating estrogen
levels in PRL-Cre/ROSA26-EYFP males after 15 days of pre-
treatment with s.c. injections of 100 mg1 7 b-estradiol dissolved in
DMSO and sesame oil, or vehicle every third day (nZ2–3).
Corresponding body weight changes are shown in panel B (mean
GS.E.M. of the mean), and pituitary weight changes are shown in
panel C. Signiﬁcance markers are relative to pituitary wet weights
at time zero. nZat least 5 for all groups.
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one used in the present study, are difﬁcult to predict or
quantify. The implication, however, is that there may be two
broad lineages of PRL cells: a GH cell-independent lineage
and a GH cell-dependent lineage that contribute differently
to overall PRL cell mass in the pituitary at different ages. In
early neonatal life where in both mice (Dolle ´ et al. 1990) and
rats (Watanabe & Haraguchi 1994) the expression of PRL
Figure 5 Changes in PRL-Cre/ROSA26-EYFP male mouse prolactinCve cells (panel A),
EYFPCve cells (panel B), GHCve cells (panel C), and transdifferentiating cells (i.e. EYFPCve,
GHCve, and prolactinKve: panel D) in response to estrogen withdrawal after high-dose
estrogen exposure for 15 days (100 mg1 7 b-estradiol dissolved in DMSO and sesame oil, or
vehicle every third day). MeansGS.E.M. are shown. *P!0.05, **P!0.01, and ***P!0.001:
nZ8 throughout. The data are summarized in panel E, where the control and vehicle-only
groupsarecombined,andthe meansofcell populations duringtheﬁrstand secondweeks after
estrogen withdrawal are also combined. Transdifferentiating cells are shown as a percentage of
total cells, and as a percentage of EYFPCve cells. Panel F shows a further summary in which
the mean proportions of EYFPCve, prolactinCve, GHCve, and transdifferentiating cells after
estrogen treatment from all time points are combined. *P!0.05, **P!0.01, and ***P!0.001.
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dependent PRL lineage perhaps accounts for a relatively
larger proportion of all PRL-containing cells. In later life,
the proportion of PRL cells that have expressed GH is
reduced to !10% of the total, perhaps through continuing
activity of oligopotent stem cells that while not responsible
for organogenesis, are nevertheless the principal source of
cell renewal and plasticity (Fauquier et al. 2008, Gleiberman
et al. 2008).
In the present study, we sought to determine whether
the potential transdifferentiation from somatotrophs to
lactotrophs may occur in reverse by tracing the fate of
lactotrophs with a transgenic mouse with the expression of
Cre recombinase driven by the rat PRL promoter. Cre
recombinase activity was monitored by crossing with
ROSA26-EYFP mice, which have a targeted insertion of
EYFP into the ROSA26 locus (Srinivas et al. 2001).
The EYFP sequences are preceded with a strong termination
sequence ﬂanked with loxP sites, and Cre recombination
leads to the removal of the termination sequence and
expression of the ﬂuorescent reporter. Once recombination
has occurred, it is permanent, and reporter expression from
the ROSA26 promoter is no longer dependent on the
expression of the recombinase. Thus, EYFP identiﬁes cells
which have expressed the transgene at any time. By crossing
these mice with ROSA26-EYFP Cre-reporter mice, we have
found that the Cre transgene leads to reporter activity almost
entirely in lactotrophs, with only a very low proportion of
somatotroph (GHCve but PRLKve) cells expressing the
EYFP reporter. Not all lactotrophs were positive for the
Cre-reporter, a ﬁnding unlikely to result from a lack of
reporter expression or detection in some lactotrophs
following Cre-mediated recombination, since in other
transgenic models expressing Cre in the pituitary, EYFP is
expressed in all lactotrophs (Arnaud Jaubert, personal
communication). No deﬁnitive conclusions about transdiffer-
entiation can be made for the population of lactotrophs that
do not express the reporter, which in female mice accounts
for about 20% of PRL-immunopositive cells, and for about
80% of PRL-immunopositive cells in male PRL-Cre/
ROSA26-EYFP mice. A similar proportion of non-
transgene-expressing PRL-immunopositive cells were found
in several other transgenic mouse lines generated by us using
the same promoter driving expression of other proteins.
This suggests that the Cre recombinase is expressed in (and
identiﬁes) a distinct, quantitatively sexually dimorphic
subpopulation of lactotrophs (M Fernandez-Fuente, personal
communications), and would ﬁt with previous descriptions
of differential secretory behavior of subpopulations of rat
lactotrophs (Christian et al. 2007). Although there are no
reasons to suspect that the populations of classical lactotrophs
that did not express the EYFP reporter are those responsible
for the bulk of transdifferentiation events, there is unfortu-
nately no way to directly disprove this possibility.
Cell counting was carried out after single cell dispersal as
the high prevalence and close proximity of GH- and
PRL-immunopositive cells together with changes in cell
size make attempts to quantify small changes in relative cell
populations in tissue sections potentially misleading. Clear
and reproducible trends at sequential time points in different
PRL/EYFP double and PRL/GH/EYFP triple immuno-
chemistry with qualitative differences in males and females
argue against the possibility of a differential detrimental effect
of cell dispersal on speciﬁc subpopulations. Aggregates were
dispersed to single cells and not ﬁltered before analysis. It
remains conceivable, however, that different cell populations
are more prone to enzyme-induced lysis or adhere
differentially to coated slides, but highly cell subpopulation-
speciﬁc effects do not seem likely, given relatively even cell
densities adherent to slides after ﬁxation. Qualitative
differences that are the same as those noted above militate
against the possibility that cell toxicity related to the
expression of Cre recombinase (Schmidt-Suppiran &
Rajewsky 2007) contributed to the changes seen in PRL-
Cre transgenic mice.
In male rats, we have shown previously that high-dose
estrogen results in a transient and surprisingly non-cell type-
speciﬁc increase in pituitary mitotic activity (Nolan & Levy
2009a,b). In the present study, whether the results were
analyzed statistically at each time point, as summations of
values during the ﬁrst and second weeks after estrogen
withdrawal, or the two combined, there was no evidence to
suggest that withdrawal of pharmacological doses of
estrogen in 6-week-old male mice resulted in a wave of
de-differentiation from PRL cells to null cells or transdiffer-
entiation from PRL cells to GH cells. Irrespective of changes
in the levels of circulating estrogen, mammosomatotroph cells
and PRL to GH transdifferentiating cells remained rare.
There was, however, an increase in the ratio of PRL cells to
GH cells in response to high-dose estrogen treatment,
corresponding to the accepted dogma of estrogen effects on
the pituitary. These ﬁndings suggest that a modest, short-term
pituitary trophic response slightly favoring PRL cells is one of
the mechanisms by which high-dose estrogen exposure in
male mice increases pituitary size.
In contrast, physiological (rather than pharmacological)
estrogen ﬂuctuations in female (rather than in male) mice
produced no such change in PRL cell/GH cell ratio.
If anything, in both PRL-Cre/ROSA-EYFP and
C57BL/6 mice, a consistent downward trend in the
percentage of PRL cells relative to other cell types was
evident at term compared with the virgin animals. During the
ﬁrst week of weaning, there appeared to be a slight upward
trend in somatotroph numbers and a decrease in lactotrophs
with a slight downward trend in total pituitary wet weight. It
is at this point that one would anticipate a signiﬁcant increase
in transdifferentiation from PRL to GH phenotype (i.e. a
cumulative increase in EYFPCve and GHCve but PRLKve
cells). This did not occur, although again the possibility that
the subpopulations of lactotrophs that do not express the
transgene are the very ones that are capable of transdiffer-
entiation cannot be discounted. However, if the increase in
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result of transdifferentiation of a proportion of the non-
transgene-expressing population, then the proportion of
lactotrophs expressing the EYFP reporter would be expected
to increase, which was not the case. The sum of GH cells
derived from lactotroph transdifferentiation did not exceed
1% of total pituitary cells present at any point, and there was
no suggestion of an increase in the rate of accumulation of
transdifferentiated cells during weaning. The lack of any
abrupt or signiﬁcant changes in the proportions of PRL cells
and GH cells in the expected direction and the absence of
any evidence of transdifferentiation suggest that changes in
overall pituitary wet weight during pregnancy and lactation
relate at least in part to an increase in the volume of
individual lactotrophs rather than to the numerical size of the
lactotroph subpopulation in relationship to other secretory
subpopulations.
Direct measurement of isolated, fresh pituitary cells
indicated that while average cell size remained the same,
EYFPCve PRL cells increased in volume by over 20%, a
ﬁnding that was supported by FACS analysis (which at face
value suggested a considerably larger volume increase).
Pituitary weights increased during the same interval (virgin
to term) by 25%. Assuming that PRL cells make up
approximately one-third of the pituitary at this time, the
increased size of individual lactotrophs would account for an
increase in overall pituitary wet weight of around 7–8%,
which is not enough to account for the 26% (from 1.82 to
2.3 mg) increase seen in PRL-Cre/ROSA26-EYFP pituitary
weight from virgin to end of ﬁrst week of lactation (or the
typical pituitary volume and weight changes seen during
pregnancy and lactation in humans (20% (Dinc et al. 1998)t o
36% (Gonzalez et al. 1988)), but a signiﬁcant contribution
nevertheless. Any further changes in pituitary volume, given
previous work (Nolan & Levy 2009b) and the absence of
evidence of transdifferentiation (measured using a cumulative
marker rather than as a rate), are likely to result from a largely
non-cell type-speciﬁc increase in mitotic activity relative to
cell death. This should not be too surprising, given that GH
cells, the other major cell subpopulation in the pituitary, are
also more active during pregnancy (Escalada et al. 1997).
Increasing cell mass of the pituitary during mouse
pregnancy could result from persistence rather than from
early apoptosis of nascent ‘transient amplifying cells’ in the
pituitary – a mechanism previously observed in response to
other changes in hormonal milieu (Nolan & Levy 2006a). If a
small proportion of nascent cells differentiate into somato-
trophs during pregnancyand lactation, somatotroph numbers,
unlike PRL cell numbers, would not fall as theyare diluted by
the increase in endocrinologically inactive cells. Differen-
tiation of endocrinologically inactive cells to somatotrophs at
weaning could produce the increase in the latter without an
increase in pituitary weight at this time, but it does not
explain the slight drop in lactotroph numbers, which must
be either dilutional or apoptotic as EYFPCve cells cannot
decrease by any other mechanism. If PRLCve to GHCve
transdifferentiation is responsible for the reciprocal changes
seen during the ﬁrst week of weaning, the decrease in the
PRLCve population would be expected to be more abrupt
than that seen in the EYFPCve population. Both decrease
almost in parallel.
Several reasons can be adduced to explain discrepancies
between our ﬁndings and published results. First, an increase
in the size of individual cells in a cellular subpopulation
produces an artifactual increase in cell counts derived from
quantiﬁcation in tissue sections (Floderus 1944). In the
present study, the changes in EYFPCve cell size would have
produced a O15% overestimation of the prevalence of this
population if it had been counted in 5-mm thick tissue
sections and directly extrapolated to volume. Secondly, cell
clumping and changes in cell contour make accurate
quantiﬁcation of prevalent subtypes in tissue sections very
difﬁcult. Thirdly, high-dose estrogen in male animals may
produce qualitatively as well as quantitatively different
pituitary effects to physiological estrogen changes in
females, and this, together with potential differences in the
origin of PRL cell populations in mice and rats, makes
extrapolations uncertain.
The most convincing evidence for changes in lactotroph
cell numbers characterized by concurrent decreases and
increases in somatotrophs during lactation and weaning used
reverse hemolytic plaque assays to detect different cell types
and bihormonal cells (Frawley & Boockfor 1991). As the
reverse hemolytic plaque assay relies on secretion to identify
cell types, it is possible that the increased number of
lactotrophs that are found during lactation result from
relatively quiescent (non-secreting) cells becoming active
during lactation, which again become quiescent at weaning.
However, this would not account for the apparently
consistent ﬁnding in Frawley’s study of rats that one-third
of all GH secretory cells released PRL, and that one-third of
all PRL cells released GH (Frawley et al. 1985). While it is
possible that these ﬁndings simply reﬂect differences between
rats and mice, differences in speciﬁcity of the methods of
detection may account for some of the inconsistencies seen.
Although differential synthesis and secretion of PRL may also
affect detection of lactotrophs by immunohistochemistry, the
use of a non-hormonal reporter gene to detect lactotrophs
overcomes this and increases the reliability of lactotroph
identiﬁcation in this study.
In summary, a signiﬁcant proportion of the increase in
pituitary size seen during pregnancy in PRL-Cre/
ROSA26-EYFP and C57BL/6 wild-type mice is the result
of an increase in mean size of individual lactotroph cells rather
than of a change in their overall number. A further relatively
modest estrogen-induced mitotic effect is likely to contribute
to pituitary weight gain, with some of the nascent cells
differentiating to the GHCve phenotype at around the time
of weaning. We were unable to ﬁnd evidence for
transdifferentiation from PRL cell to GH cell or from PRL
cell to null cell as a mechanism associated with pituitary
cell population changes during reproduction: the caveat
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best 79% of PRLCve lactotrophs. Mammosomatotroph
cells in male and female adult mice are relatively rare, and
if lactotroph transition through a mammosomatotroph
phenotype does occur, it remains a feature of organogenesis
rather than a plastic response to physiological stimuli in
adulthood.
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